Full title: A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
Age: 12+ years
Phase: 1b/2
Locations:
- London – University College London Hospital, Royal Marsden Hospital
- Manchester – The Christie
- Oxford – Oxford University Hospital
Brief summary:
EMBOLD Sarcoma-202 is an international clinical trial testing a drug called Risvutatug Rezetecan. Researchers want to know if this medicine can help people with advanced or metastatic sarcomas, whether its safe to use, how well people handle the drug, as well as how its absorbed and broken down by the body. This research is for adolescents and adults with either osteosarcoma or soft tissue sarcoma which has already been treated, but has come back or spread, and can’t be removed by surgery.
More information can be found at clinicaltrials.gov
To find out more about this trial and whether you could take part, talk to your clinical team.
